4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine
C20H18F2N4S2 — CID 146874312
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine
4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine (PubChem CID 146874312) has the molecular formula C20H18F2N4S2 and a molecular weight of 416.52 g/mol. Its IUPAC name is 4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine.
Molecular Properties
| Compound Name | 4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine |
|---|---|
| PubChem CID | 146874312 |
| Molecular Formula | C20H18F2N4S2 |
| Molecular Weight | 416.52 g/mol |
| Exact Mass | 416.09 |
| IUPAC Name | 4,6-difluoro-N-[2-[(2S,3R)-2-methylpiperidin-3-yl]thieno[2,3-b]pyridin-4-yl]-1,3-benzothiazol-5-amine |
| SMILES | C[C@@H]1NCCC[C@H]1c1cc2c(Nc3c(F)cc4scnc4c3F)ccnc2s1 |
| InChI | InChI=1S/C20H18F2N4S2/c1-10-11(3-2-5-23-10)15-7-12-14(4-6-24-20(12)28-15)26-18-13(21)8-16-19(17(18)22)25-9-27-16/h4,6-11,23H,2-3,5H2,1H3,(H,24,26)/t10-,11+/m0/s1 |
| InChIKey | SPEXZELPTDKCSI-WDEREUQCSA-N |
| XLogP | 5.78 |
| TPSA | 49.84 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 416.52 |
| LogP ≤ 5 | 5.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146874312 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.